Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.
Bärbel HuberClaus KellerMartin JenkinsAbid RazaMagnus AurivilliusPublished in: Therapeutic advances in respiratory disease (2022)
Dual therapy with BFF MDI and with BUD/FORM DPI led to improvements in lung function in patients with severe-to-very severe COPD and low PIF.